Skip to main content

Advertisement

Table 4 Patients characteristics related to morality

From: Risk factors and treatment of pneumothorax secondary to granulomatosis with polyangiitis: a clinical analysis of 25 cases

Clinical features Death group(n = 10) Survival group P value
   (n = 12)  
Male/Female(n) 7(70.0%)/3(30.0%) 8(80.0%)/4(40.0%) 1.000
Age (years) 53 ± 12.9(33~70) 40 ± 14.7(25~70) 0.050
Duration (weeks) 19 ± 24.8(10~48) 34 ± 69.2(0.83~216) 0.547
Extrapulmonary manifestations (n)    
 Fever 3 (30.0%) 7 (58.3%) 0.231
 Skin lesions (purpura, gangrene, ulceration) 3 (30.0%) 3 (25.0%) 1.000
 Ear (hearing loss, otitis media) 2 (20.0%) 4 (33.3%) 0.646
 Nasal and sinus involvement 5 (50.0%) 7 (58.3%) 1.000
 Oral ulceration 4 (40.0%) 1 (8.3%) 0.135
 glomerulonephritis 6 (60.0%) 6 (50.0%) 0.691
 Nervous system (facial paralysis, multiple mononeuropathy, etc.) 3 (30.0%) 1 (8.3%) 0.293
 Arthralgia/arthritis 4 (40.0%) 4 (33.3%) 1.000
 Parotid swelling and pain 2 (20.0%) 0 (0.0%) 0.195
ESR(mm/h) 104 ± 26.7 82 ± 33.9 0.233
Infection(n) 6 (60.0%) 3 (25.0%) 0.192
Corticosteroids and Immunosuppressants (n)    
 steroid pulse therapy 1 (10.0%) 4 (33.3%) 0.323
 treatment interruption 2/4(50.0%) 0/8(0.0%) 0.091
Non-response to Pleural drainage (n) 5/5 (100%) 0/7 (0.0%) 0.010
Surgery(n) 2 (20.0%) 5 (41.7%) 0.381
  1. Note: 3 cases without prognostic information, n = 22 cases; ESR, erythrocyte sedimentation rate